Timing of multikinase inhibitor initiation in differentiated thyroid cancer

There are limited treatment options for patients with radioactive iodine refractory, progressive differentiated thyroid cancer. Although there is consensus that multikinase inhibitor therapy should be considered in patients with progressive disease with considerable tumor load or symptomatic disease...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Endocr Relat Cancer
Asıl Yazarlar: Brose, Marcia S, Smit, Johannes, Lin, Chia-Chi, Pitoia, Fabian, Fellous, Marc, DeSanctis, Yoriko, Schlumberger, Martin, Tori, Masayuki, Sugitani, Iwao
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bioscientifica Ltd 2017
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446590/
https://ncbi.nlm.nih.gov/pubmed/28270435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-17-0016
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller